Pakistan · Delayed Price · Currency is PKR IBL HealthCare Statistics
Total Valuation
IBL HealthCare has a market cap or net worth of PKR 5.65 billion. The enterprise value is 6.08 billion.
| Market Cap | 5.65B |
| Enterprise Value | 6.08B |
Important Dates
The next estimated earnings date is Wednesday, February 18, 2026.
| Earnings Date | Feb 18, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
IBL HealthCare has 98.53 million shares outstanding. The number of shares has increased by 0.18% in one year.
| Current Share Class | 98.53M |
| Shares Outstanding | 98.53M |
| Shares Change (YoY) | +0.18% |
| Shares Change (QoQ) | +0.66% |
| Owned by Insiders (%) | 1.15% |
| Owned by Institutions (%) | 6.51% |
| Float | 26.78M |
Valuation Ratios
The trailing PE ratio is 25.94.
| PE Ratio | 25.94 |
| Forward PE | n/a |
| PS Ratio | 1.29 |
| PB Ratio | 2.36 |
| P/TBV Ratio | 2.36 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.19, with an EV/FCF ratio of -75.44.
| EV / Earnings | 27.88 |
| EV / Sales | 1.39 |
| EV / EBITDA | 13.19 |
| EV / EBIT | 13.42 |
| EV / FCF | -75.44 |
Financial Position
The company has a current ratio of 2.00, with a Debt / Equity ratio of 0.19.
| Current Ratio | 2.00 |
| Quick Ratio | 1.27 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | 0.99 |
| Debt / FCF | -5.66 |
| Interest Coverage | 8.23 |
Financial Efficiency
Return on equity (ROE) is 9.55% and return on invested capital (ROIC) is 10.41%.
| Return on Equity (ROE) | 9.55% |
| Return on Assets (ROA) | 7.22% |
| Return on Invested Capital (ROIC) | 10.41% |
| Return on Capital Employed (ROCE) | 18.79% |
| Revenue Per Employee | 19.48M |
| Profits Per Employee | 974,085 |
| Employee Count | 224 |
| Asset Turnover | 1.11 |
| Inventory Turnover | 2.62 |
Taxes
In the past 12 months, IBL HealthCare has paid 174.25 million in taxes.
| Income Tax | 174.25M |
| Effective Tax Rate | 44.40% |
Stock Price Statistics
The stock price has increased by +70.14% in the last 52 weeks. The beta is 0.67, so IBL HealthCare's price volatility has been lower than the market average.
| Beta (5Y) | 0.67 |
| 52-Week Price Change | +70.14% |
| 50-Day Moving Average | 53.67 |
| 200-Day Moving Average | 46.07 |
| Relative Strength Index (RSI) | 47.47 |
| Average Volume (20 Days) | 2,842,573 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IBL HealthCare had revenue of PKR 4.36 billion and earned 218.20 million in profits. Earnings per share was 2.21.
| Revenue | 4.36B |
| Gross Profit | 1.50B |
| Operating Income | 453.21M |
| Pretax Income | 392.45M |
| Net Income | 218.20M |
| EBITDA | 457.26M |
| EBIT | 453.21M |
| Earnings Per Share (EPS) | 2.21 |
Balance Sheet
The company has 24.03 million in cash and 456.76 million in debt, giving a net cash position of -432.73 million or -4.39 per share.
| Cash & Cash Equivalents | 24.03M |
| Total Debt | 456.76M |
| Net Cash | -432.73M |
| Net Cash Per Share | -4.39 |
| Equity (Book Value) | 2.39B |
| Book Value Per Share | 24.29 |
| Working Capital | 1.77B |
Cash Flow
In the last 12 months, operating cash flow was -59.51 million and capital expenditures -21.15 million, giving a free cash flow of -80.65 million.
| Operating Cash Flow | -59.51M |
| Capital Expenditures | -21.15M |
| Free Cash Flow | -80.65M |
| FCF Per Share | -0.82 |
Margins
Gross margin is 34.46%, with operating and profit margins of 10.38% and 5.00%.
| Gross Margin | 34.46% |
| Operating Margin | 10.38% |
| Pretax Margin | 8.99% |
| Profit Margin | 5.00% |
| EBITDA Margin | 10.48% |
| EBIT Margin | 10.38% |
| FCF Margin | n/a |
Dividends & Yields
IBL HealthCare does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 0.01% |
| Buyback Yield | -0.18% |
| Shareholder Yield | -0.18% |
| Earnings Yield | 3.86% |
| FCF Yield | -1.43% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 7, 2025. It was a forward split with a ratio of 1.15.
| Last Split Date | Oct 7, 2025 |
| Split Type | Forward |
| Split Ratio | 1.15 |
Scores
IBL HealthCare has an Altman Z-Score of 3.69 and a Piotroski F-Score of 4.
| Altman Z-Score | 3.69 |
| Piotroski F-Score | 4 |